Pliant Therapeutics, Inc.
PLRX
$1.49
$0.042.76%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 262.87M | 305.65M | 355.72M | 404.51M | 436.61M |
| Total Receivables | 1.54M | 1.68M | 2.30M | 2.22M | 2.80M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.28M | 1.72M | 2.98M | 1.85M | 6.31M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.76M | 2.14M | 1.26M | 1.45M | 1.83M |
| Total Current Assets | 267.44M | 311.19M | 362.26M | 410.03M | 447.55M |
|
|
|||||
| Total Current Assets | 267.44M | 311.19M | 362.26M | 410.03M | 447.55M |
| Net Property, Plant & Equipment | 30.51M | 31.67M | 32.77M | 33.73M | 34.26M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.87M | 1.91M | 1.92M | 1.91M | 1.92M |
| Total Assets | 299.82M | 344.77M | 396.95M | 445.67M | 483.73M |
|
|
|||||
| Total Accounts Payable | 1.38M | 5.62M | 5.96M | 6.89M | 3.25M |
| Total Accrued Expenses | 17.98M | 21.81M | 26.72M | 32.74M | 27.58M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.23M | 771.00K | 542.00K | 322.00K | 98.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 20.59M | 28.20M | 33.22M | 39.95M | 30.92M |
|
|
|||||
| Total Current Liabilities | 20.59M | 28.20M | 33.22M | 39.95M | 30.92M |
| Long-Term Debt | 30.36M | 30.28M | 30.21M | 30.14M | 30.07M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 28.79M | 29.12M | 29.44M | 29.75M | 30.06M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 79.74M | 87.61M | 92.87M | 99.84M | 91.05M |
|
|
|||||
| Common Stock & APIC | 1.03B | 1.02B | 1.01B | 1.01B | 995.85M |
| Retained Earnings | -809.52M | -766.22M | -710.05M | -660.32M | -602.56M |
| Treasury Stock & Other | -1.00K | 159.00K | 321.00K | 848.00K | -617.00K |
| Total Common Equity | 220.08M | 257.16M | 304.08M | 345.82M | 392.68M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 220.08M | 257.16M | 304.08M | 345.82M | 392.68M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 220.08M | 257.16M | 304.08M | 345.82M | 392.68M |
|
|
|||||